CST BLOG: Lab Expectations

The official blog of Cell Signaling Technology (CST) where we discuss what to expect from your time at the bench, share tips, tricks, and information.

Mechanisms of Cell Death: Ferroptosis

Read More
All Posts

Ferroptosis is a recently described form of programmed cell death with distinct morphological and biochemical characteristics. It does not result in the chromatin condensation observed during apoptosis or the loss of plasma membrane integrity that occurs during necrosis. Rather, it is morphologically characterized by the presence of condensed mitochondria, reduction in mitochondrial cristae, and increased membrane densities.

eBook: Researcher's Guide to Mechanisms of Cell Death

Ferritin & Iron Homeostasis

Ferroptosis is an iron-dependent cell death that results in an increase in lipid peroxides. As such, it is largely regulated by pathways that contribute to iron homeostasis and oxidative stress. Iron homeostasis is controlled, in part, by ferritin, or FTH, which is a large protein complex that is responsible for the transport of iron in its non-toxic form. Ferritin levels can be regulated by a selective autophagy process targeting ferritin, termed ferritinophagy. This pathway is mediated by a selective cargo receptor for ferritin called nuclear receptor coactivator 4 (NCOA4). Ferroptosis has been shown to be inhibited with the use of some common iron chelators, such as deferoxamine.

Defense Against Oxidative Stress

Pathways regulating cellular defense against oxidative stress are critical to mitigate ferroptosis. Small-molecule lipophilic free radical scavengers, like ferrostatin-1 and liproxstatin-1, can inhibit ferroptosis. The glutathione pathway, in particular, has been identified as a key antioxidant defense pathway. A central player in this process is the metabolic protein glutathione peroxidase 4 (GPX4), which converts GSH into oxidized glutathione (GSSH), thus protecting cells against ferroptosis by limiting cytotoxic lipid peroxidation. The glutathione peroxidase pathway is further regulated by System Xc-, an amino acid antiporter consisting of a heterodimer of xCT/SLC7A11 and SLC3A2 (4F2hc/CD98), which is critical for glutathione (GSH) synthesis. Importantly, one way to induce ferroptosis is to use the compound erastin, which directly inhibits the function of System Xc-.

Regulation of genes involved in oxidative stress, including GPX4, is largely controlled by the transcription factor NRF2. This serves as a critical defense against ferroptosis. Under normal conditions, expression of NRF2 is inhibited through interaction with KEAP1, part of a ubiquitin E3 ligase complex that leads to NRF2 proteasomal degradation. Oxidative stress leads to conformation changes in KEAP1 that disrupts this interaction, resulting in the stabilization of NRF2. This process is further regulated through the autophagy pathway in which the autophagy cargo receptor p62/SQSTM1 can competitively inhibit the KEAP1-NRF2 complex leading to the upregulation of NRF2.

Antibody Tools for Studying Ferroptosis

Tools to monitor ferroptosis may involve multiple approaches, including pharmacological sensitivity (such as iron chelators, antioxidants), changes in expression of targets (GPX4, SCL7A11, ferritin, NRF2, etc.), monitoring reactive oxygens and lipid peroxidation, and glutathione assays.

CST offers an antibody sampler kit that contains these and other antibodies to help you identify proteins relevant to your research and focus your initial efforts: Ferroptosis Antibody Sampler Kit #29650.

Additional Resources

To find out more about the mechanisms, morphology, and target proteins involved in many types of cell death, download the Researcher's Guide to Mechanisms of Cell Death.

Read the additional blog posts in the Mechanisms of Cell Death series: 

Learn more about CST® TUNEL kits that robustly detect cells undergoing apoptosis and other forms of programmed cell death.


Select References

20-CEP-94379
Gary Kasof, PhD
Gary Kasof, PhD
Dr. Gary Kasof is a Senior Research Fellow working on antibody development and has been at Cell Signaling Technology for over 17 years. He has contributed to the release of nearly 1000 antibodies in several research areas, most notable in cell death and autophagy. Prior to CST he received his PhD from Columbia University in 1995, and has worked at Rutgers University and AstraZeneca.

Related Posts

Introducing the Winners of the 4th Annual Rising Black Scientists Awards

We’re thrilled to announce the winners of the 4th annual Rising Black Scientists Awards essay competition...
Reaiah Johnson Feb 15, 2024

CUT&Tag DNA Library Yield: What to Do if Yours Is Too Low to Detect with an Agilent Bioanalyzer or TapeStation System

Chromatin profiling with methods like ChIP-Seq, CUT&RUN, and now CUT&Tag have significantly contr...
Andrea Tu, PhD Feb 5, 2024

How to Perfect Your Elevator Pitch

Networking and self-promotion are essential parts of any scientist's career, and while many might find th...
Alexandra Foley Dec 20, 2023